Eversept Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Eversept Partners’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-345,717	Closed	-$15.5M	–	108
2021 Q1	$15.5M	Buy	345,717 +99,477	+40%	+$4.63M	1.17%	29
2020 Q4	$14.1M	Sell	246,240 -156,193	-39%	-$9.26M	1.65%	20
2020 Q3	$20.6M	Sell	402,433 -16,219	-4%	-$795K	4.59%	9
2020 Q2	$25M	Buy	418,652 +4,571	+1%	+$245K	3.43%	11
2020 Q1	$17M	Buy	414,081 +285,333	+222%	+$15.8M	4.24%	8
2019 Q4	$8.01M	Buy	128,748 +106,748	+485%	+$5.07M	1.42%	20
2019 Q3	$747K	Sell	22,000 -283,233	-93%	-$8.38M	0.23%	47
2019 Q2	$6.88M	Buy	305,233 +54,801	+22%	+$1.28M	1.93%	13
2019 Q1	$5.81M	Buy	250,432 +180,732	+259%	+$4.73M	1.7%	17
2018 Q4	$1.46M	Buy	+69,700	New	+$1.71M	0.79%	25
2018 Q3	–	Sell	-9,536	Closed	-$375K	–	76
2018 Q2	$375K	Sell	9,536 -75,554	-89%	-$2.22M	0.17%	66
2018 Q1	$1.71M	Buy	+85,090	New	+$2.16M	0.79%	27

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Eversept Partners's DCPH Position: Q2 2021 in Review

Eversept Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 345,717 shares — an estimated $15.5M sold.

Eversept Partners first reported a position in DCPH in Q1 2018 and held it in 12 quarters. The position peaked at $25M in Q2 2020. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

Eversept Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Eversept Partners sold 345,717 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $15.5M.
Eversept Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 12 quarters.
Eversept Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $25M in Q2 2020.
147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Eversept Partners's 13F filing for Q2 2021, filed 16 Aug 2021.